Rising Chronic Diseases Propel Canada Pharmaceutical Market Towards USD 41.94 Billion by 2029

Mordor Intelligence has published a new report on the Canada Pharmaceutical Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The Canada Pharmaceutical Market is projected to be valued at USD 33.34 billion in 2024 and is anticipated to grow to USD 41.94 billion by 2029, registering a Compound Annual Growth Rate (CAGR) of 4.70% during the forecast period (2024-2029). The increasing geriatric population and the growing prevalence of chronic diseases are anticipated to drive the growth of the pharmaceutical market in Canada.

Report Overview: https://www.mordorintelligence.com/industry-reports/canada-pharmaceutical-market

Key Trends Driving the Canada Pharmaceutical Market

Rising Prevalence of Chronic Diseases

Canada is witnessing a surge in chronic diseases, including cancer, cardiovascular disorders, and diabetes. According to the Canadian Cancer Society's 2023 report, approximately 239,100 new cancer cases were expected to be diagnosed in Canada in 2023. This escalating burden necessitates the development and distribution of effective pharmaceutical treatments, thereby propelling market growth.

Aging Population Driving Pharmaceutical Demand

The aging demographic in Canada significantly contributes to the pharmaceutical market's expansion. Statistics Canada reported that about 7.6 million people aged 65 and older were living in Canada in 2023, with projections indicating this number could reach 11 million by 2043. Older adults are more susceptible to various health conditions, increasing the demand for medications and healthcare services.

Advancements in Pharmaceutical Research and Development

Continuous innovation in pharmaceutical research has led to the introduction of new and effective drugs. Biopharmaceutical companies are investing heavily in research and development to address unmet medical needs, resulting in a robust pipeline of novel therapeutics. This trend is expected to sustain market growth over the forecast period.

Government Initiatives and Healthcare Policies

The Canadian government is actively involved in healthcare reforms and policies aimed at improving access to medications. Initiatives such as the Pan-Canadian Pharmaceutical Alliance (pCPA) work towards reducing drug prices and enhancing affordability, which can influence market dynamics positively.

Market Segmentation

The Canadian pharmaceutical market is segmented based on therapeutic class and drug type:

By Therapeutic Class:

Alimentary Tract and Metabolism: Medications addressing digestive system disorders and metabolic conditions.

Blood and Blood-Forming Organs: Drugs related to hematological conditions.

Cardiovascular System: Pharmaceuticals targeting heart and circulatory system diseases.

Dermatologicals: Medications for skin-related conditions.

Genito Urinary System and Sex Hormones: Drugs affecting reproductive and urinary systems.

Systemic Hormonal Preparations: Hormone therapies excluding sex hormones.

Anti-infectives for Systemic Use: Antibiotics and antiviral medications.

Antineoplastic and Immunomodulating Agents: Cancer therapies and immune system modulators.

Musculoskeletal System: Drugs for bone and muscle disorders.

Nervous System: Medications targeting neurological conditions.

Antiparasitic Products, Insecticides, and Repellents: Drugs combating parasitic infections.

Respiratory System: Pharmaceuticals for respiratory ailments.

Sensory Organs: Medications for eye and ear conditions.

Various Other Therapeutic Classes: Drugs not classified elsewhere.

By Drug Type:

Prescription Drugs: Medications requiring a healthcare provider's authorization.

Branded: Original products developed by pharmaceutical companies.

Generic: Non-branded drugs equivalent to branded counterparts.

Over-the-Counter (OTC) Drugs: Medications available without a prescription.

Get a Customized Report Tailored to Your Requirements: https://www.mordorintelligence.com/market-analysis/pharmaceuticals

Key Players

The Canadian pharmaceutical market is characterized by the presence of several key players contributing to its development:

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

Bayer AG

Novartis AG

These companies are at the forefront of pharmaceutical innovation, investing in research and development to introduce new therapies that meet the evolving healthcare needs of the Canadian population.

Industry Related Reports

Cancer Vaccines Market: The Global Cancer Vaccine Market is categorized by Technology (Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, and Other Technologies), Treatment Method (Preventive Vaccines and Therapeutic Vaccines), Application (Prostate Cancer, Cervical Cancer, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/cancer-vaccines-market

Hepatitis Therapeutics Market: The report highlights Hepatitis B Treatment Market Trends, segmented by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, and Other Types), Drug Class (Interferon, Monoclonal Antibody, Non-structural Protein 5A (NS5A) Inhibitors, Nucleotide Analog Reverse Transcriptase Inhibitors, Nucleotide Analog NS5B Polymerase Inhibitors, Multi-Class Combination, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/hepatitis-therapeutics-market

Biomedical 3D Printing Materials Market: The Biocompatible 3D Printing Materials Market Report is divided by Material Type (Polymer, Metal, and Other Material Types), Application (Implants & Prostheses, Prototyping & Surgical Guides, Tissue Engineering, Hearing Aids, and Other Applications), Form (Powder and Liquid), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

To know more visit this link: https://www.mordorintelligence.com/industry-reports/biomedical-3d-printing-materials-market

Conclusion

The Canadian pharmaceutical market is on a robust growth trajectory, driven by the rising prevalence of chronic diseases, an aging population, and continuous advancements in pharmaceutical research and development. Government initiatives aimed at improving healthcare access and affordability further bolster this growth. As the healthcare landscape continues to evolve, the pharmaceutical market in Canada is expected to expand, offering opportunities for manufacturers and healthcare providers to meet the diverse needs of patients across the nation.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.